Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Taiwan ETF
EWT
|
+$89.9M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$71.9M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$69M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$66M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$58.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$33M |
| 2 |
Altria Group
MO
|
+$32.4M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$26.5M |
| 4 |
CVS Health
CVS
|
+$24.7M |
| 5 |
Medtronic
MDT
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 17.23% |
| 2 | Technology | 14.6% |
| 3 | Healthcare | 11.36% |
| 4 | Industrials | 11.26% |
| 5 | Consumer Discretionary | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1476
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $32K | ﹤0.01% |
+24,289
| New | +$35.1K |
2017 Q2
0 quarters
|
|
1477
DELISTED
Real Industry, Inc.
RELY
| $32K | ﹤0.01% |
+11,046
| New | +$30.1K |
2017 Q2
0 quarters
|
|
|
IMBI
1478
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $31K | ﹤0.01% |
3,110
| – | – |
2016 Q4
2 quarters
|
|
1479
Novavax
NVAX
$1.78B
| $30K | ﹤0.01% |
1,284
-3,806
| -75% | -$74.7K |
2016 Q4
2 quarters
|
|
1480
Rocket Pharmaceuticals
RCKT
$261M
| $28K | ﹤0.01% |
+3,719
| New | +$27.7K |
2017 Q2
0 quarters
|
|
1481
Verastem
VSTM
$1.06B
| $28K | ﹤0.01% |
1,075
-417
| -28% | -$10.6K |
2016 Q4
2 quarters
|
|
1482
Apyx Medical
APYX
$123M
| $27K | ﹤0.01% |
10,800
-9,000
| -45% | -$22.1K |
2017 Q1
1 quarter
|
|
|
SRNE
1483
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $27K | ﹤0.01% |
+13,602
| New | +$26.5K |
2017 Q2
0 quarters
|
|
1484
DELISTED
Adverum Biotechnologies
ADVM
| $26K | ﹤0.01% |
1,030
-24
| -2% | -$656 |
2017 Q1
1 quarter
|
|
|
ANTH
1485
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $24K | ﹤0.01% |
+14,888
| New | +$33.4K |
2017 Q2
0 quarters
|
|
|
JONE
1486
DELISTED
Jones Energy, Inc.
JONE
| $23K | ﹤0.01% |
718
+204
| +40% | +$8.24K |
2016 Q4
2 quarters
|
|
|
PPP
1487
DELISTED
Primero Mining Corp
PPP
| $23K | ﹤0.01% |
65,143
+49,511
| +317% | +$22.5K |
2016 Q4
2 quarters
|
|
|
INFI
1488
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $22K | ﹤0.01% |
+14,126
| New | +$27.2K |
2017 Q2
0 quarters
|
|
1489
Vince Holding Corp
VNCE
$164M
| $17K | ﹤0.01% |
+3,627
| New | +$25.9K |
2017 Q2
0 quarters
|
|
1490
SELLAS Life Sciences
SLS
$1.7B
| $12K | ﹤0.01% |
+14
| New | +$12.2K |
2017 Q2
0 quarters
|
|
1491
DELISTED
Avinger, Inc. Common Stock
AVGR
| – | – |
0
| – | – |
2017 Q2
0 quarters
|
|
|
TVIA
1492
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
| $11K | ﹤0.01% |
+49,147
| New | +$17.8K |
2017 Q2
0 quarters
|
|
1493
Tandem Diabetes Care
TNDM
$1.18B
| $9K | ﹤0.01% |
+1,165
| New | +$10.8K |
2017 Q2
0 quarters
|
|
|
AMPE
1494
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $9K | ﹤0.01% |
+59
| New | +$11.9K |
2017 Q2
0 quarters
|
|
|
ARGS
1495
DELISTED
Argos Therapeutics, Inc.
ARGS
| $5K | ﹤0.01% |
+715
| New | +$6.09K |
2017 Q2
0 quarters
|
|
1496
Alcoa
AA
$10.4B
| – | – |
-98,590
| Closed | -$3.39M | – |
|
1497
Advance Auto Parts
AAP
$2.75B
| – | – |
-17,125
| Closed | -$2.54M | – |
|
1498
Acadia Pharmaceuticals
ACAD
$3.67B
| – | – |
-65,586
| Closed | -$2.26M | – |
|
1499
Acco Brands
ACCO
$467M
| – | – |
-17,163
| Closed | -$226K | – |
|
1500
Ares Commercial Real Estate
ACRE
$203M
| – | – |
-13,400
| Closed | -$179K | – |
|
Similar funds
Squarepoint's Q2 2017 Portfolio in Review
As of Q2 2017, Squarepoint held 2,064 positions worth $5.08B, up 40% from $3.63B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Squarepoint deployed $1.39B of net new capital in Q2 2017, opening 586 new positions and adding to 519 existing holdings. Its largest new stake was iShares MSCI Taiwan ETF: 2,618,387 shares worth $93.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, an estimated $33M trimmed.
- Squarepoint's largest Q2 2017 buy was iShares MSCI Taiwan ETF: 2,618,387 shares worth $93.6M.
- Squarepoint added most to VanEck Gold Miners ETF in Q2 2017, an estimated $71.9M increase.
- Squarepoint's biggest Q2 2017 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $33M.
- Squarepoint fully exited iShares MSCI EAFE ETF in Q2 2017, selling an estimated $26.5M.
- Squarepoint's ten largest holdings make up 16% of its $5.08B portfolio in Q2 2017.
- Squarepoint opened 586 new positions and closed 568 in Q2 2017.
- Squarepoint's portfolio value rose 40% quarter-over-quarter to $5.08B.
Based on Squarepoint's 13F filing for Q2 2017, filed 14 Aug 2017.